BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7015437)

  • 1. [Nutritive effects of an intestinal alpha-glucosidases-inhibition in rats (author's transl)].
    Kirchgessner M; Roth FX; Spoerl R
    Res Exp Med (Berl); 1981; 178(3):211-7. PubMed ID: 7015437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nutrient digestibility and N-balance after administration of an alpha-glucosidase inhibitor to pigs].
    Roth FX; Kirchgessner M
    Z Tierphysiol Tierernahr Futtermittelkd; 1980; 44(2):57-63. PubMed ID: 6252715
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of inhibition of intestinal glucosidase on protein and energy balance in rats].
    Kirchgessner M; Spoerl R; Roth FX
    Ann Nutr Metab; 1981; 25(3):194-200. PubMed ID: 7025747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Puls W
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
    O'Dea K; Turton J
    Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Thomas G; Puls W
    Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR; Ebert R; Creutzfeldt W
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):81-6. PubMed ID: 375342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.
    Walton RJ; Sherif IT; Noy GA; Alberti KG
    Br Med J; 1979 Jan; 1(6158):220-1. PubMed ID: 369651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Glucosidase inhibition in obesity.
    William-Olsson T
    Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha-amylase and alpha-glucosidase inhibitors on caries incidence and plaque accumulation in rats.
    Mörmann JE; Schmid R; Mühlemann HR
    Caries Res; 1983; 17(4):353-6. PubMed ID: 6191863
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats.
    Madar Z
    J Nutr; 1989 Dec; 119(12):2023-9. PubMed ID: 2695605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a glucosidase inhibitor on the metabolic response of diabetic rats to a high carbohydrate diet, consisting of starch and sucrose, or glucose.
    Gray RS; Olefsky JM
    Metabolism; 1982 Jan; 31(1):88-92. PubMed ID: 7043164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal glycogen storage induced by Acarbose, a 1,4-alpha-glucosidase inhibitor.
    Geddes R; Taylor JA
    Biochem J; 1985 Jun; 228(2):319-24. PubMed ID: 3893420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor.
    Zavaroni I; Reaven GM
    Metabolism; 1981 Apr; 30(4):417-20. PubMed ID: 7010078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
    Kotler DP; Tierney AR; Kral JG; Bjorntorp P
    Am J Clin Nutr; 1984 Aug; 40(2):270-6. PubMed ID: 6380264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of alpha-glucosidase inhibition on intestinal disaccharidase activity in normal and diabetic mice.
    Lee SM; Bustamante SA; Koldovský O
    Metabolism; 1983 Aug; 32(8):793-9. PubMed ID: 6346004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.